Magnetic resonance (MR) safety and compatibility of a novel iron bioresorbable scaffold
- PMID: 32128465
- PMCID: PMC7044471
- DOI: 10.1016/j.bioactmat.2020.02.011
Magnetic resonance (MR) safety and compatibility of a novel iron bioresorbable scaffold
Abstract
Fully bioresorbable scaffolds have been designed to overcome the limitations of traditional drug-eluting stents (DESs), which permanently cage the native vessel wall and pose possible complications. The ultrathin-strut designed sirolimus-eluting iron bioresorbable coronary scaffold system (IBS) shows comparable mechanical properties to traditional DESs and exhibits an adaptive degradation profile during target vessel healing, which makes it a promising candidate in all-comers patient population. For implanted medical devices, magnetic resonance (MR) imaging properties, including MR safety and compatibility, should be evaluated before its clinical use, especially for devices with intrinsic ferromagnetism. In this study, MR safety and compatibility of the IBS scaffold were evaluated based on a series of well-designed in-vitro, ex-vivo and in-vivo experiments, considering possible risks, including scaffold movement, over-heating, image artifact, and possible vessel injury, under typical MR condition. Traditional ASTM standards for MR safety and compatibility evaluation of intravascular devices were referred, but not only limited to that. The unique time-relevant MR properties of bioresorbable scaffolds were also discussed. Possible forces imposed on the scaffold during MR scanning and MR image artifacts gradually decreased along with scaffold degradation/absorption. Rigorous experiments designed based on a scientifically based rationale revealed that the IBS scaffold is MR conditional, though not MR compatible before complete absorption. The methodology used in the present study can give insight into the MR evaluation of magnetic scaffolds (bioresorbable) or stents (permanent).
Keywords: Artifact; Iron bioresorbable scaffold; MR compatibility; MR safety; Magnetic resonance imaging (MRI).
© 2020 Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
Conflict of interest statement
The authors declared no conflict of interest.
Figures











Similar articles
-
Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model.Bioact Mater. 2024 May 18;39:135-146. doi: 10.1016/j.bioactmat.2024.05.027. eCollection 2024 Sep. Bioact Mater. 2024. PMID: 38783928 Free PMC article.
-
Preclinical Evaluation of a Novel Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold in Porcine Coronary Artery at 6 Months.JACC Cardiovasc Interv. 2019 Feb 11;12(3):245-255. doi: 10.1016/j.jcin.2018.10.020. JACC Cardiovasc Interv. 2019. PMID: 30732729
-
Randomized Comparison of Absorb Bioresorbable Vascular Scaffold and Mirage Microfiber Sirolimus-Eluting Scaffold Using Multimodality Imaging.JACC Cardiovasc Interv. 2017 Jun 12;10(11):1115-1130. doi: 10.1016/j.jcin.2017.03.015. Epub 2017 May 17. JACC Cardiovasc Interv. 2017. PMID: 28527768 Clinical Trial.
-
Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.Lancet. 2016 Feb 6;387(10018):537-544. doi: 10.1016/S0140-6736(15)00979-4. Epub 2015 Nov 17. Lancet. 2016. PMID: 26597771 Review.
-
From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.Expert Rev Med Devices. 2016;13(3):271-86. doi: 10.1586/17434440.2016.1143356. Epub 2016 Feb 12. Expert Rev Med Devices. 2016. PMID: 26782080 Review.
Cited by
-
Advances in the development of biodegradable coronary stents: A translational perspective.Mater Today Bio. 2022 Jul 19;16:100368. doi: 10.1016/j.mtbio.2022.100368. eCollection 2022 Dec. Mater Today Bio. 2022. PMID: 35937578 Free PMC article. Review.
-
Medical Imaging Compatibility of Magnesium- and Iron-Based Bioresorbable Flow Diverters.AJNR Am J Neuroradiol. 2023 Jun;44(6):668-674. doi: 10.3174/ajnr.A7873. Epub 2023 May 11. AJNR Am J Neuroradiol. 2023. PMID: 37169543 Free PMC article.
-
In Vivo Imaging of Biodegradable Implants and Related Tissue Biomarkers.Polymers (Basel). 2021 Jul 17;13(14):2348. doi: 10.3390/polym13142348. Polymers (Basel). 2021. PMID: 34301105 Free PMC article. Review.
-
Advances and perspective on the translational medicine of biodegradable metals.Biomater Transl. 2021 Sep 28;2(3):177-187. doi: 10.12336/biomatertransl.2021.03.002. eCollection 2021. Biomater Transl. 2021. PMID: 35836654 Free PMC article. Review.
-
Long-term efficacy, safety and biocompatibility of a novel sirolimus eluting iron bioresorbable scaffold in a porcine model.Bioact Mater. 2024 May 18;39:135-146. doi: 10.1016/j.bioactmat.2024.05.027. eCollection 2024 Sep. Bioact Mater. 2024. PMID: 38783928 Free PMC article.
References
-
- Garg S., Serruys P.W. Coronary stents: looking forward. J. Am. Coll. Cardiol. 2010;56(10):S43–S78. - PubMed
-
- Zheng Y.F., Gu X.N., Witte F. Biodegradable metals. Math. Sci. Eng. R. 2014;77:1–34. 0.
-
- Indolfi C., Rosa S.D., Colombo A. Bioresorbable vascular scaffolds - basic concepts and clinical outcome. Nat. Rev. Cardiol. 2016;13(12):719–729. - PubMed
-
- Serruys P.W.J.C., Onuma Y. CRC Press; 2017. Bioresorbable Scaffolds: from Basic Concept to Clinical Applications.
-
- Zhu Y.Q., Yang K., Cheng R.Y., Xiang Y., Yuan T.W., Cheng Y.S., Sarmento B., Cui W.G. The current status of biodegradable stent to treat benign luminal disease. Mater. Today. 2017;20(9):516–529.
LinkOut - more resources
Full Text Sources